The pair rule, the rounding trap that turns a JW line into a JZ line, what an unprocessable return really costs, and the federal refund program your JW units quietly feed.
Medicare pays an ASC 100 percent of the highest national ASC rate in a session and 50 percent of every other discountable procedure. This page shows how the ranking is decided, which procedures escape the cut, and where the money actually leaks.
How to tailor claims, patient statements and superbills to Medicare, Medicaid, commercial and workers’ comp payers, with the fields and deadlines that change for each one.
What flags a pharmacy for a PBM audit, which records answer each finding, how long to keep them, and how six state audit laws limit recoupment.
Six places to buy outsourced eligibility verification, what each costs per check, the in-house math, and why eligibility denials continue after you outsource.
The five records that make a panniculectomy reconstructive rather than cosmetic, how Medicare prior authorization and dual diagnosis coding work for 15830, and where 15847 fits.
Retroactive Part D DIR fees ended in 2024, yet pharmacies still lose money after a claim pays. Where it goes in 2026, how to find it on an 835 and what it costs per claim.
How to split one operation between payer and patient: claim the reconstructive codes, quote the cosmetic fee plus the time it adds, and time each portion.
A due diligence checklist for vetting a billing company’s HIPAA, OIG and fee compliance, plus the raw data that proves it is transparent.
What MolDX is, which states it covers, where the DEX Z-Code goes on each claim type, and why a molecular claim without one denies unprocessable rather than landing on a denial report.